CVS Group’s (CVSG) Buy Rating Reaffirmed at Peel Hunt

CVS Group (LON:CVSG)‘s stock had its “buy” rating restated by equities researchers at Peel Hunt in a report released on Friday. They presently have a GBX 1,350 ($18.65) price target on the stock. Peel Hunt’s target price suggests a potential upside of 20.54% from the company’s previous close.

Separately, Berenberg Bank reiterated a “buy” rating and set a GBX 1,450 ($20.03) price target on shares of CVS Group in a research note on Wednesday, December 6th.

CVS Group (LON CVSG) opened at GBX 1,120 ($15.47) on Friday. The stock has a market capitalization of $723.06 and a price-to-earnings ratio of 6,222.22. CVS Group has a 12 month low of GBX 13.22 ($0.18) and a 12 month high of GBX 1,500 ($20.72).

In other news, insider Richard A. Connell purchased 2,061 shares of the business’s stock in a transaction dated Thursday, December 7th. The stock was bought at an average price of GBX 920 ($12.71) per share, for a total transaction of £18,961.20 ($26,196.74).

WARNING: This report was published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at

About CVS Group

CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals.

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit